Elligo Health Research Acquires ClinEdge in $135M Transaction

September 23, 2021

Elligo Health Research completed the acquisition of ClinEdge (including GuideStar Research and BTC of New Bedford) as part of a $135 million financing led by Morgan Stanley Expansion Capital and Ally Bridge Group, with participation from Norwest Venture Partners and existing investors. The deal expands Elligo’s global scale and capabilities by combining ClinEdge’s research practice management and clinical services with Elligo’s IntElligo technology, EHR-derived data access, and trial-acceleration platform.

Buyers
Elligo Health Research, Morgan Stanley Expansion Capital, Ally Bridge Group, Norwest Venture Partners, Cerner, Hatteras Venture Partners, Noro-Moseley Partners, Piper Sandler Merchant Banking, Shumway Capital, Syneos Health
Targets
ClinEdge, GuideStar Research, BTC of New Bedford
Location
Massachusetts, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.